I don’t think the difference between the way the companies are approaching GvHD is difficult to explain. But I do agree with you that it could be made clearer, and an update following MSB’s approval would be welcome. I would expect them to be touring the US and EU with a new presentation including this. But as you say, we will find out relatively quickly given the Bioweek conference is only 2 weeks away, so arguing the point is redundant.
CYP Price at posting:
21.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)